227 related articles for article (PubMed ID: 24583601)
21. Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis.
Gadalla R; Hassan H; Ibrahim SA; Abdullah MS; Gaballah A; Greve B; El-Deeb S; El-Shinawi M; Mohamed MM
Breast Cancer Res Treat; 2019 Apr; 174(3):679-691. PubMed ID: 30632021
[TBL] [Abstract][Full Text] [Related]
22. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells.
Yi T; Zhai B; Yu Y; Kiyotsugu Y; Raschle T; Etzkorn M; Seo HC; Nagiec M; Luna RE; Reinherz EL; Blenis J; Gygi SP; Wagner G
Proc Natl Acad Sci U S A; 2014 May; 111(21):E2182-90. PubMed ID: 24782546
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
24. Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib.
Dillmann F; Veldwijk MR; Laufs S; Sperandio M; Calandra G; Wenz F; Zeller J; Fruehauf S
Leuk Lymphoma; 2009 Oct; 50(10):1676-86. PubMed ID: 19657955
[TBL] [Abstract][Full Text] [Related]
25. Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
Hattermann K; Holzenburg E; Hans F; Lucius R; Held-Feindt J; Mentlein R
Cell Tissue Res; 2014 Jul; 357(1):253-66. PubMed ID: 24770893
[TBL] [Abstract][Full Text] [Related]
26. CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy.
Zhang F; Gong S; Wu J; Li H; Oupicky D; Sun M
Biomacromolecules; 2017 Jun; 18(6):1793-1802. PubMed ID: 28445650
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.
Cronin PA; Wang JH; Redmond HP
BMC Cancer; 2010 May; 10():225. PubMed ID: 20492653
[TBL] [Abstract][Full Text] [Related]
28. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
29. Wnt pathway activity in breast cancer sub-types and stem-like cells.
Lamb R; Ablett MP; Spence K; Landberg G; Sims AH; Clarke RB
PLoS One; 2013; 8(7):e67811. PubMed ID: 23861811
[TBL] [Abstract][Full Text] [Related]
30. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
31. Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells.
Mukherjee S; Manna A; Bhattacharjee P; Mazumdar M; Saha S; Chakraborty S; Guha D; Adhikary A; Jana D; Gorain M; Mukherjee SA; Kundu GC; Sarkar DK; Das T
Oncogene; 2016 Sep; 35(37):4937-48. PubMed ID: 26923331
[TBL] [Abstract][Full Text] [Related]
32. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
33. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
[TBL] [Abstract][Full Text] [Related]
34. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
35. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Lombardo Y; Filipović A; Molyneux G; Periyasamy M; Giamas G; Hu Y; Trivedi PS; Wang J; Yagüe E; Michel L; Coombes RC
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16558-63. PubMed ID: 23012411
[TBL] [Abstract][Full Text] [Related]
36. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
Sengupta S; Schiff R; Katzenellenbogen BS
Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
[TBL] [Abstract][Full Text] [Related]
37. Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).
Wang R; Yang L; Li S; Ye D; Yang L; Liu Q; Zhao Z; Cai Q; Tan J; Li X
Med Sci Monit; 2018 Jan; 24():412-420. PubMed ID: 29353288
[TBL] [Abstract][Full Text] [Related]
38. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
Schabath H; Runz S; Joumaa S; Altevogt P
J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
[TBL] [Abstract][Full Text] [Related]
39. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
[TBL] [Abstract][Full Text] [Related]
40. Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.
López-Mateo I; Alonso-Merino E; Suarez-Cabrera C; Park JW; Cheng SY; Alemany S; Paramio JM; Aranda A
Thyroid; 2020 Jan; 30(1):116-132. PubMed ID: 31760908
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
